REQUEST A DEMO
Total
USD $0.00
Search more companies

Shruti Drugs Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shruti Drugs Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Shruti Drugs Private Limited is a company in India, with a head office in Hyderabad. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on July 11, 1994. It currently has a total number of 1 - 10 (2024) employees. There was a net sales revenue increase of 35.6% reported in Shruti Drugs Private Limited’s latest financial highlights for 2025. There was a total growth of 13.54% in Shruti Drugs Private Limited’s total assets over the same period. The net profit margin of Shruti Drugs Private Limited increased by 0.02% in 2025.

Legal Address
5-4-187/7-3Mahatma Gandhi Road
Hyderabad; Telangana; Postal Code: 500003

Contact Details: Purchase the Shruti Drugs Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Shruti Drugs Private Limited report to view the information.
Registered Capital:
Purchase the Shruti Drugs Private Limited report to view the information.
Financial Auditors:
Purchase the Shruti Drugs Private Limited report to view the information.
Incorporation Date:
July 11, 1994
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Shruti Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
35.6%
Total Operating Revenue
34.54%
Operating Profit
64.11%
EBITDA
82.57%
Net Profit/Loss for the Period
37.3%
Total Assets
13.54%
Total Equity
11.66%
Operating Profit Margin
1.05%
Net Profit Margin
0.02%
Return on Equity (ROE)
1.95%
Debt / Equity
34%
Quick Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?